Icon (ICLR) Capital Expenditure

: $-140.69 Mil (TTM As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Icon's cash flow for capital expenditures for the three months ended in Dec. 2023 was $-53 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Dec. 2023 was $-140.69 Mil.

Icon Capital Expenditure Historical Data

The historical data trend for Icon's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icon Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Capital Expenditure

Get a 7-Day Free Trial

-38.95

-40.89

-93.75

-142.16

-140.69

Icon Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Capital Expenditure	Get a 7-Day Free Trial															-57.02	-26.74	-32.14	-29.10	-52.71

Icon Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-140.69 Mil.

Icon (ICLR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » Capital Expenditure

Comparable Companies

Traded in Other Exchanges

ICLR:Mexico IJF:Germany

Address

South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3

Website

https://www.iconplc.com

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.